|
SURVIVORS (invasive, n = 15: in situ, n = 3)
|
NON-SURVIVORS (invasive n = 18)
|
|---|
|
Alive and well
|
Death from “Disseminated breast cancer”
|
|---|
|
Age at surgery (yrs)
|
Post-op follow-up survival (yrs)
|
Cancer size (mm)
|
Cancer “grade”
|
Involved lymph nodes
|
Nottingham prognostic Index
|
Age at surgery (yrs)
|
Post-op follow-up survival (yrs)
|
Cancer size (mm)
|
Cancer “grade”
|
Involved lymph nodes
|
Nottingham prognostic index
|
|---|
|
54.15
|
15.39
|
15
|
2
|
1
|
4.30
|
41.87
|
0.76
|
120
|
3
|
2
|
7.40
|
|
40.84
|
19.12
|
50
|
1
|
0
|
3.00
|
46.46
|
1.16
|
21
|
3
|
4
|
6.42
|
|
36.48
|
19.39
|
80
|
3
|
0
|
5.60
|
39.61
|
1.90
|
40
|
3
|
2
|
5.80
|
|
41.68
|
19.93
|
20
|
3
|
0
|
4.40
|
37.83
|
2.28
|
15
|
3
|
0
|
4.30
|
|
32.70
|
20.32
|
*
|
3
|
0
|
In situ
|
56.57
|
2.50
|
20
|
3
|
5
|
6.40
|
|
40.08
|
20.50
|
8
|
2
|
0
|
3.16
|
26.90
|
2.69
|
20
|
3
|
1
|
5.40
|
|
37.50
|
20.67
|
28
|
3
|
0
|
4.56
|
43.78
|
4.21
|
18
|
2
|
0
|
3.36
|
|
34.23
|
21.04
|
35
|
2
|
0
|
3.70
|
28.07
|
5.43
|
19
|
2
|
0
|
3.38
|
|
42.97
|
21.96
|
*
|
-
|
0
|
In situ
|
38.45
|
5.60
|
30
|
3
|
1
|
5.60
|
|
42.26
|
23.35
|
*
|
-
|
0
|
In situ
|
37.45
|
6.79
|
25
|
3
|
0
|
4.50
|
|
41.15
|
23.50
|
10 (?)
|
3
|
0
|
4.20
|
43.69
|
8.01
|
30
|
1
|
1
|
3.60
|
|
36.76
|
24.08
|
35
|
2
|
0
|
3.70
|
39.22
|
8.07
|
30
|
3
|
1
|
5.60
|
|
34.80
|
24.38
|
20
|
3
|
0
|
4.40
|
40.73
|
8.46
|
15
|
2
|
0
|
3.30
|
|
32.47
|
24.83
|
8
|
3
|
0
|
4.16
|
44.02
|
9.32
|
15
|
2
|
0
|
3.30
|
|
34.84
|
25.04
|
30
|
3
|
0
|
4.60
|
42.43
|
13.11
|
45
|
3
|
1
|
5.90
|
|
35.98
|
25.41
|
40
|
3
|
0
|
4.80
|
38.46
|
15.73
|
8
|
2
|
0
|
3.16
|
|
38.03
|
26.19
|
57
|
2
|
0
|
4.15
|
31.75
|
21.16
|
10
|
3
|
0
|
4.20
|
|
34.08
|
28.14
|
10
|
3
|
0
|
4.20
|
34.59
|
22.82
|
15
|
3
|
0
|
4.30
|
- *Score not possible where cancer was “in situ” (i.e., non-invasive).
